News

not found

Novo Nordisk briefly overtakes LVMH as Europe's most valuable company

Danish drugmaker Novo Nordisk unseated LVMH  as Europe's most valuable listed company on Friday, ending the French luxury group's 2-1/2 year-long reign at the top. LVMH, the world's biggest luxury retailer, has been hurt by growing concerns about the outlook for the Chinese economy. Novo is meanwhile riding a wave of demand for its highly effective diabetes and weight-loss drugs Ozempic and Wegovy, which has sent its earnings and shares to record highs. Its shares have risen around 17% since it announced on Aug. 8 that a large study had shown Wegovy also had a clear cardiovascular benefit, boosting the company's hopes of moving beyond its image as a lifestyle drug. As of Friday's close, Novo Nordisk had a market capitalisation of around $424.7 billion including unlisted stock, according to Refinitiv data and company disclosures of its share count. French-listed LVMH had a market cap of $420.1 billion, having been Europe's biggest listed company since February 2021 when it knocked consumer goods group Nestle off the top spot. 23-year timeline of Europe's largest company 23-year timeline of Europe's largest company Novo's share price has roughly tripled in the past three years while that of LVMH, home to fashion labels Louis Vuitton and Dior, has doubled. "Novo closing in on LVMH as Europe's biggest market cap stock is a reflection of Novo's recent product success while LVMH's recent trends have been more mixed," said Marcel Stotzel, co-portfolio manager of Fidelity European Fund and Fidelity European Trust.

  • 6 September, 09:06
  • Read more
not found

Vitamin C and E supplements may make lung cancers grow faster

Supplementing with antioxidants such as vitamins C and E could increase the formation of blood vessels within lung cancer tumours, helping them to grow bigger and spread, according to a study in mice. Taking antioxidant supplements such as vitamins C and E may cause lung cancers to grow bigger and spread by stimulating the formation of blood vessels within tumours, according to a study in mice. One researcher has stressed that people with the condition shouldn’t try to avoid these antioxidants in their diet, but getting more than they need via supplements could cause harm. Martin Bergö at the Karolinska Institute in Sweden and his colleagues previously found that supplementing with the antioxidants vitamin E and n-acetylcysteine caused lung cancers to spread in mice. To better understand how this might occur, Bergö and a new team of researchers studied mice with a murine-specific form of lung cancer and mice that had been implanted with human lung cancer cells. They supplemented the mice’s water with vitamin C, which the animals naturally produce, and vitamin E and n-acetylcysteine, which they get from their diet. These supplements were administered at increasing doses, all of which caused the mice’s levels of these antioxidants to exceed what was necessary. “Today in society, you have a lot of people who eat healthily, they have some supplements, and then they may have a ginger shot and a smoothie,” says Bergö. “If you do all that, you could end up with the levels of doses that we’re talking about.”

  • 4 September, 10:28
  • Read more
Нажмите на кнопку ниже, чтобы прослушать текст Powered by GSpeech